Renlun Huang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Targeting UBE2T by β-elemene inhibits prostate cancer stem cells and bone metastasis by blocking the TRIM28/pGSK3β/β-catenin signaling.

Targeting UBE2T by β-elemene inhibits prostate cancer stem cells and bone metastasis by blocking the TRIM28/pGSK3β/β-catenin signaling.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 15, 2025

System Analysis Identifies MYBL2 As a Novel Oncogene Target for Metastatic Prostate Cancer.

System Analysis Identifies MYBL2 As a Novel Oncogene Target for Metastatic Prostate Cancer.

Journal: Journal of Cancer

Published: November 19, 2024

Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.

Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.

Journal: Chinese journal of natural medicines

Published: December 12, 2023

Upregulation of CKS2 in immunosuppressive cells is associated with metastasis and poor prognosis in prostate cancer: a single-cell RNA-sequencing analysis.

Upregulation of CKS2 in immunosuppressive cells is associated with metastasis and poor prognosis in prostate cancer: a single-cell RNA-sequencing analysis.

Journal: Translational cancer research

Published: November 14, 2023

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.

Journal: PloS one

Published: April 15, 2023

Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.

Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.

Journal: Frontiers in pharmacology

Published: March 16, 2022

Do disease status and race affect the efficacy of zoledronic acid in patients with prostate cancer? A systematic review and meta-analysis of randomized control trials.

Do disease status and race affect the efficacy of zoledronic acid in patients with prostate cancer? A systematic review and meta-analysis of randomized control trials.

Journal: PloS one

Published: November 25, 2021

Research Trends and Regulation of CCL5 in Prostate Cancer.

Research Trends and Regulation of CCL5 in Prostate Cancer.

Journal: OncoTargets and therapy

Published: August 28, 2020

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.

Journal: Cell death & disease

Published: December 05, 2019

XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.

XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.

Journal: Frontiers in pharmacology

Published: July 13, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026